150 related articles for article (PubMed ID: 33539629)
21. Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.
Balakrishnan K; Burger JA; Fu M; Doifode T; Wierda WG; Gandhi V
Neoplasia; 2014 Dec; 16(12):1036-46. PubMed ID: 25499217
[TBL] [Abstract][Full Text] [Related]
22. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.
Lagneaux L; Delforge A; Bron D; De Bruyn C; Stryckmans P
Blood; 1998 Apr; 91(7):2387-96. PubMed ID: 9516138
[TBL] [Abstract][Full Text] [Related]
23. Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia.
Fecteau JF; Messmer D; Zhang S; Cui B; Chen L; Kipps TJ
Blood; 2013 Feb; 121(6):971-4. PubMed ID: 23255557
[TBL] [Abstract][Full Text] [Related]
24. Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.
Niemann CU; Herman SE; Maric I; Gomez-Rodriguez J; Biancotto A; Chang BY; Martyr S; Stetler-Stevenson M; Yuan CM; Calvo KR; Braylan RC; Valdez J; Lee YS; Wong DH; Jones J; Sun C; Marti GE; Farooqui MZ; Wiestner A
Clin Cancer Res; 2016 Apr; 22(7):1572-82. PubMed ID: 26660519
[TBL] [Abstract][Full Text] [Related]
25. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
Hegde GV; Peterson KJ; Emanuel K; Mittal AK; Joshi AD; Dickinson JD; Kollessery GJ; Bociek RG; Bierman P; Vose JM; Weisenburger DD; Joshi SS
Mol Cancer Res; 2008 Dec; 6(12):1928-36. PubMed ID: 19074837
[TBL] [Abstract][Full Text] [Related]
26. LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia.
Nguyen PH; Fedorchenko O; Rosen N; Koch M; Barthel R; Winarski T; Florin A; Wunderlich FT; Reinart N; Hallek M
Cancer Cell; 2016 Oct; 30(4):610-622. PubMed ID: 27728807
[TBL] [Abstract][Full Text] [Related]
27. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.
Ghosh AK; Secreto CR; Knox TR; Ding W; Mukhopadhyay D; Kay NE
Blood; 2010 Mar; 115(9):1755-64. PubMed ID: 20018914
[TBL] [Abstract][Full Text] [Related]
28. Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling.
Jitschin R; Braun M; Qorraj M; Saul D; Le Blanc K; Zenz T; Mougiakakos D
Blood; 2015 May; 125(22):3432-6. PubMed ID: 25778534
[TBL] [Abstract][Full Text] [Related]
29. Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.
Davids MS; Deng J; Wiestner A; Lannutti BJ; Wang L; Wu CJ; Wilson WH; Brown JR; Letai A
Blood; 2012 Oct; 120(17):3501-9. PubMed ID: 22955911
[TBL] [Abstract][Full Text] [Related]
30. PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.
El-Gamal D; Williams K; LaFollette TD; Cannon M; Blachly JS; Zhong Y; Woyach JA; Williams E; Awan FT; Jones J; Andritsos L; Maddocks K; Wu CH; Chen CS; Lehman A; Zhang X; Lapalombella R; Byrd JC
Blood; 2014 Aug; 124(9):1481-91. PubMed ID: 25001469
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Fas-associated death domain recruitment by histone deacetylase inhibitors is critical for the sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis.
Inoue S; Harper N; Walewska R; Dyer MJ; Cohen GM
Mol Cancer Ther; 2009 Nov; 8(11):3088-97. PubMed ID: 19887558
[TBL] [Abstract][Full Text] [Related]
32. PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.
Holler C; Piñón JD; Denk U; Heyder C; Hofbauer S; Greil R; Egle A
Blood; 2009 Mar; 113(12):2791-4. PubMed ID: 19168795
[TBL] [Abstract][Full Text] [Related]
33. In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment.
Kriston C; Plander M; Márk Á; Sebestyén A; Bugyik E; Matolcsy A; Barna G
Ann Hematol; 2018 Nov; 97(11):2145-2152. PubMed ID: 29955944
[TBL] [Abstract][Full Text] [Related]
34. The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells.
Fiorcari S; Brown WS; McIntyre BW; Estrov Z; Maffei R; O'Brien S; Sivina M; Hoellenriegel J; Wierda WG; Keating MJ; Ding W; Kay NE; Lannutti BJ; Marasca R; Burger JA
PLoS One; 2013; 8(12):e83830. PubMed ID: 24376763
[TBL] [Abstract][Full Text] [Related]
35. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia.
Zhang W; Trachootham D; Liu J; Chen G; Pelicano H; Garcia-Prieto C; Lu W; Burger JA; Croce CM; Plunkett W; Keating MJ; Huang P
Nat Cell Biol; 2012 Feb; 14(3):276-86. PubMed ID: 22344033
[TBL] [Abstract][Full Text] [Related]
36. Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia.
Mangolini M; Götte F; Moore A; Ammon T; Oelsner M; Lutzny-Geier G; Klein-Hitpass L; Williamson JC; Lehner PJ; Dürig J; Möllmann M; Rásó-Barnett L; Hughes K; Santoro A; Méndez-Ferrer S; Oostendorp RAJ; Zimber-Strobl U; Peschel C; Hodson DJ; Schmidt-Supprian M; Ringshausen I
Nat Commun; 2018 Sep; 9(1):3839. PubMed ID: 30242258
[TBL] [Abstract][Full Text] [Related]
37. An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease.
Giannoni P; Scaglione S; Quarto R; Narcisi R; Parodi M; Balleari E; Barbieri F; Pattarozzi A; Florio T; Ferrini S; Corte G; de Totero D
Haematologica; 2011 Jul; 96(7):1015-23. PubMed ID: 21486864
[TBL] [Abstract][Full Text] [Related]
38. Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production.
Lagneaux L; Delforge A; Dorval C; Bron D; Stryckmans P
Blood; 1993 Oct; 82(8):2379-85. PubMed ID: 7691258
[TBL] [Abstract][Full Text] [Related]
39. Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cells.
Vangapandu HV; Chen H; Wierda WG; Keating MJ; Korkut A; Gandhi V
Leuk Lymphoma; 2018 Jun; 59(6):1427-1438. PubMed ID: 28971726
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL.
Yosifov DY; Idler I; Bhattacharya N; Reichenzeller M; Close V; Ezerina D; Scheffold A; Jebaraj BMC; Kugler S; Bloehdorn J; Bahlo J; Robrecht S; Eichhorst B; Fischer K; Weigel A; Busch H; Lichter P; Döhner H; Dick TP; Stilgenbauer S; Mertens D
Leukemia; 2020 Jan; 34(1):115-127. PubMed ID: 31300746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
